Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research

被引:85
作者
Wang, Zhixiang [1 ,2 ]
机构
[1] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada
[2] Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada
关键词
EGF receptor; G protein-coupled receptors; mechanisms; cancer; MEDIATED EGFR TRANSACTIVATION; LUNG-CANCER CELLS; SIGNALING PATHWAYS CONTRIBUTES; TUMOR SUPPRESSOR GPRC5A; FACTOR-BETA RECEPTOR; SMOOTH-MUSCLE-CELLS; MAP KINASE PATHWAYS; PHOSPHOLIPASE C-GAMMA-1; TYROSINE KINASES; GABA(B) RECEPTOR;
D O I
10.3390/ijms17010095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both G protein-coupled receptors (GPCRs) and receptor-tyrosine kinases (RTKs) regulate large signaling networks, control multiple cell functions and are implicated in many diseases including various cancers. Both of them are also the top therapeutic targets for disease treatment. The discovery of the cross-talk between GPCRs and RTKs connects these two vast signaling networks and complicates the already complicated signaling networks that regulate cell signaling and function. In this review, we focus on the transactivation of epidermal growth factor receptor (EGFR), a subfamily of RTKs, by GPCRs. Since the first report of EGFR transactivation by GPCR, significant progress has been made including the elucidation of the mechanisms underlying the transactivation. Here, we first provide a basic picture for GPCR, EGFR and EGFR transactivation by GPCR. We then discuss the progress made in the last five years and finally provided our view of the future challenge and future researches needed to overcome these challenges.
引用
收藏
页数:12
相关论文
共 101 条
[1]   Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor [J].
Akhtar, Saghir ;
Chandrasekhar, Bindu ;
Attur, Sreeja ;
Dhaunsi, Gursev S. ;
Yousif, Mariam H. M. ;
Benter, Ibrahim F. .
PLOS ONE, 2015, 10 (11)
[2]   Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway [J].
Akhtar, Saghir ;
Yousif, Mariam H. M. ;
Dhaunsi, Gursev S. ;
Chandrasekhar, Bindu ;
Al-Farsi, Omama ;
Benter, Ibrahim F. .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (05) :1390-1400
[3]   Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway [J].
Amorino, G. P. ;
Deeble, P. D. ;
Parsons, S. J. .
ONCOGENE, 2007, 26 (05) :745-756
[4]   ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics [J].
Arteaga, Carlos L. ;
Engelman, Jeffrey A. .
CANCER CELL, 2014, 25 (03) :282-303
[5]   MAP kinase pathways: The first twenty years [J].
Avruch, Joseph .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (08) :1150-1160
[6]   Crosstalk between G-protein-coupled receptors and Epidermal growth factor receptor in cancer [J].
Bhola, Neil E. ;
Grandis, Jennifer R. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 :1857-1865
[7]   Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab [J].
Bhola, Neil E. ;
Thomas, Sufi M. ;
Freilino, Maria ;
Joyce, Sonali ;
Sahu, Anirban ;
Maxwell, Jessica ;
Argiris, Athanassios ;
Seethala, Raja ;
Grandis, Jennifer R. .
CLINICAL CANCER RESEARCH, 2011, 17 (15) :4996-5004
[8]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[9]   Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells [J].
Brusevold, Ingvild J. ;
Tveteraas, Ingun H. ;
Aasrum, Monica ;
Odegard, John ;
Sandnes, Dagny L. ;
Christoffersen, Thoralf .
BMC CANCER, 2014, 14
[10]   PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION [J].
BURGERING, BMT ;
COFFER, PJ .
NATURE, 1995, 376 (6541) :599-602